Position in NEO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,265,913
+$1,458,275 QoQ
Shares Held
223,846
-8.1% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#59
of 266 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $17,367,922 across 10 Diagnostics & Research names. NEO ranks #2 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDNT |
RadNet, Inc.
|
116,506 | $7,184,925 | |
| 2 | NEO |
Neogenomics Inc
This page
|
223,846 | $3,265,913 | |
| 3 | VCYT |
Veracyte, Inc.
|
52,337 | $3,073,752 | |
| 4 | DGX |
Quest Diagnostics Inc
|
4,281 | $907,357 | |
| 5 | CSTL |
Castle Biosciences Inc
|
31,748 | $757,189 | |
| 6 | GRAL |
GRAIL, Inc.
|
8,696 | $593,675 | |
| 7 | MYGN |
Myriad Genetics Inc
|
97,375 | $556,011 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
2,831 | $547,005 |
All Filings in NEO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,265,913 | 223,846 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,807,638 | 243,617 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||